欢迎访问尚科生物医药（上海）有限公司

logo

logo

NEWS CENTER
Company News Industry News
Check category
Homepage
-
News
-
Industry News
Research progress on enzymatic synthesis of potential precursors of Clenbuterol in cooperation between Norwegian University of Science and Technology and Shangke Biomedical

Research progress on enzymatic synthesis of potential precursors of Clenbuterol in cooperation between Norwegian University of Science and Technology and Shangke Biomedical

Clenbuterol, is a β2-adrenergic agonist (β2-adrenergic agonist), similar to ephedrine (Ephedrine), is often used clinically to treat chronic obstructive pulmonary disease (COPD), It is also used as a bronchodilator to relieve acute exacerbations of asthma.

MORE
Pre
1
Research progress on enzymatic synthesis of potential precursors of Clenbuterol in cooperation between Norwegian University of Science and Technology and Shangke Biomedical
Research progress on enzymatic synthesis of potential precursors of Clenbuterol in cooperation between Norwegian University of Science and Technology and Shangke Biomedical
Clenbuterol, is a β2-adrenergic agonist (β2-adrenergic agonist), similar to ephedrine (Ephedrine), is often used clinically to treat chronic obstructive pulmonary disease (COPD), It is also used as a bronchodilator to relieve acute exacerbations of asthma.
Read more >>
Previous page
1
×

Search

Search
这是描述信息

Copyright ©SyncoZymes (Shanghai) Co., Ltd.      沪ICP备09012407号 By:300.cn

×